Press Release
Category Added in a WPeMatico Campaign
-
ViGenCell’s VT-EBV-N Selected for Oral Presentation at ASCO 2026
Phase 2 study of EBV-specific T cell therapy to be presented at a leading oncology meeting SEOUL, South Korea, April…
Read More » -
BCE reports results of Series AG and AH Preferred Share conversions
MONTRÉAL, April 21, 2026 /PRNewswire/ – BCE Inc. (TSX: BCE) (NYSE: BCE) today announced that 121,070 of its 8,032,285 fixed-rate…
Read More » -
Johnny Lieberman of Harbor IT named Entrepreneur Of The Year® 2026 New York finalist by EY US
NEW YORK, April 21, 2026 /PRNewswire/ — Johnny Lieberman, founder and CEO of Harbor IT, has been named a finalist for…
Read More » -
TCL Launches its First UltraThin Designer Series Soundbar
Big Cinematic Sound in a Small Elegant Form IRVINE, Calif., April 21, 2026 /PRNewswire/ — TCL®, one of the world’s…
Read More » -
Pinion Partners23 hours ago
“Jimmie” A Story of Resilience, Family, and Unconventional Love Now Available from Heritage Book Publishing
Pompano Beach, FL Heritage Book Publishing proudly announces the release of Jimmie, a powerful and deeply personal novel by second-time…
Read More » -
SMASHIFY LAUNCHES BETA PLATFORM TO REWRITE THE STREAMING EXPERIENCE FOR ARTIST AND FANS
The Way the World Streams Music Is About to Change LOS ANGELES, April 21, 2026 /PRNewswire/ — Smashify announced today…
Read More » -
Business Wire24 hours ago
PowerTransitions to Enter New York Market with Acquisition of 323 MW of Operating Power Generation Assets
HOUSTON–(BUSINESS WIRE)–PowerTransitions®, a leading independent power producer specializing in the redevelopment of legacy power and industrial facilities, announced today that…
Read More » -
Synergen Rx Launches New Website to Elevate Specialty Pharmacy Experience for Patients, Providers, and Manufacturers
Enhanced digital platform reflects Synergen Rx’s national capabilities, high-touch care model, and commitment to innovation in specialty pharmacy. ATLANTA, April…
Read More » -
Rockefeller Foundation Accelerates U.S. Economic Solutions at “Big Bets for America: Baltimore”
More than 250 U.S. leaders from across philanthropy, policy, the private sector, and nonprofits to surface and scale bold solutions…
Read More » -
Nuvation Bio Announces IBTROZI® (Taletrectinib) Showed Highly Durable Responses in Longer-Term Follow-up Data from Pivotal Studies Presented at AACR 2026
Analysis of longer-term pooled data from TRUST-I and TRUST-II demonstrated nearly 50 months median duration of response and 46.1 months…
Read More »







